Patents by Inventor Charles Diliberti

Charles Diliberti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080070882
    Abstract: The present invention is directed to pharmaceutical vaginal cream compositions comprising a conjugated estrogen and a stabilizer. The present invention is also directed to a method of treating a menopausal condition in a female in need thereof, said method comprising vaginally administering a pharmaceutical vaginal cream composition comprising a conjugated estrogen twice per week for at least 2 weeks.
    Type: Application
    Filed: August 17, 2007
    Publication date: March 20, 2008
    Inventors: Salah Ahmed, Charles Diliberti, Carole Ben-Maimon, Howard Hait
  • Publication number: 20070218517
    Abstract: The present invention relates to methods of determining the immunogenic potential of a test product by comparing the immunogenic profile or fingerprint of the test product to the immunogenic profile or fingerprint of a reference product.
    Type: Application
    Filed: March 20, 2007
    Publication date: September 20, 2007
    Inventors: Charles DiLIBERTI, Alan Liss
  • Publication number: 20070111975
    Abstract: The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days, optionally followed by a hormone-free period or by a period of administration of estrogen. The disclosed regimens can be administered to a female to provide contraceptive and non-contraceptive benefits.
    Type: Application
    Filed: October 30, 2006
    Publication date: May 17, 2007
    Applicant: Duramed Pharmaceuticals, Inc.
    Inventors: Charles Diliberti, Kathleen Reape, Lance Bronnenkant
  • Publication number: 20060275360
    Abstract: The present invention relates to an oral pharmaceutical dosage form comprising micronized progesterone, an edible oil, a disintegrant, and a hydrophilic excipient. Particularly, the invention relates to a pharmaceutical dosage form wherein the dosage form is in a powder form and is contained in a pharmaceutically acceptable capsule. The present invention is also directed toward methods of making the dosage form, methods of using the dosage form, and kits comprising the dosage form.
    Type: Application
    Filed: May 26, 2006
    Publication date: December 7, 2006
    Inventors: Salah Ahmed, Charles Diliberti, Chandra Vattikonda, Sudhir Gorukanti, Sanjeev Gupta
  • Publication number: 20060183724
    Abstract: The present invention relates to compositions containing unconjugated estrogens and methods of their use in the treatment of conditions associated with hypoestrogenism or reduced estrogen levels in females.
    Type: Application
    Filed: February 3, 2006
    Publication date: August 17, 2006
    Inventors: Charles Diliberti, Anu Mahashabde
  • Publication number: 20060135496
    Abstract: The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days, optionally followed by a hormone-free period or by a period of administration of estrogen. The disclosed regimens can be administered to a female to provide contraceptive and non-contraceptive benefits.
    Type: Application
    Filed: October 7, 2005
    Publication date: June 22, 2006
    Applicant: Duramed Pharmaceuticals, Inc.
    Inventors: Charles DiLiberti, Kathleen Reape, Lance Bronnenkant
  • Publication number: 20060040904
    Abstract: The present invention is directed to pharmaceutical vaginal cream compositions comprising a conjugated estrogen and a stabilizer. The present invention is also directed to a method of treating a menopausal condition in a female in need thereof, said method comprising vaginally administering a pharmaceutical vaginal cream composition comprising a conjugated estrogen twice per week for at least 2 weeks.
    Type: Application
    Filed: August 17, 2004
    Publication date: February 23, 2006
    Inventors: Salah Ahmed, Charles Diliberti, Carole Ben-Maimon, Howard Hait